Skip to search formSkip to main contentSkip to account menu

vascular endothelial growth factor-165

Known as: VEGF-165 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
INTRODUCTION Pterygium is a conjunctival fibrovascular tissue growth on the cornea. The pathogenesis of pterygium involves… 
2011
2011
Objective—Tissue kallikrein, a widely used vasodilator for the treatment of hypertension and peripheral circulatory disorder… 
2010
2010
Myocardial capillary density and angiogenesis are impaired during aging but whether growth factor therapy is able to induce… 
2008
2008
BACKGROUND Vascular endothelial growth factor (VEGF)-165 promotes cardiomyogenesis in chronic myocardial ischemia and… 
2007
2007
Vascular endothelial growth factor (VEGF) is an important vasodilator and effector of permeability in systemic blood vessels… 
2007
2007
BackgroundAngiogenesis can be enhanced by several growth factors, like vascular endothelial growth factor-165 (VEGF165) and basic… 
2004
2004
AIM To investigate the designation, synthesis and biological activity of against vascular endothelial growth factor165 (VEGF165… 
2002
2002
AIM To investigate the effect of antisense RNA to vascular endothelial growth factor165 (VEGF165) on human esophageal squamous… 
2000
2000
Milas and co-workers(1) reported in a recent issue of the Journal a potential adjuvant effect of selective cyclooxygenase-2 (COX…